How big is the Immunohematology Market?
According to 6Wresearch internal database and industry insights, the Immunohematology Market was valued at USD 2.4 Billion in 2024 and is projected to reach USD 3.5 Billion by 2031, growing at a compound annual growth rate of 5.5% during the forecast period (2025–2031).
The market growth is driven by increasing demand for safe blood transfusions, advanced testing technologies, and growing awareness about blood-related disorders.
Key Growth Drivers of the Immunohematology Market
- Increasing number of surgical procedures and trauma cases
-
- Rising need for safe and compatible blood transfusions
- Advancements in immunohematology diagnostics and instruments
- Government initiatives promoting blood donation and safety
- Expansion of healthcare infrastructure in emerging economies
Immunohematology Market Trends
The immunohematology market is witnessing major advancements in automation and integration of AI in blood typing and cross-matching systems. There's a rising trend of adopting molecular immunohematology techniques for higher precision in identifying rare blood types. Portable immunohematology analyzers are gaining traction in emergency and field settings. Cloud-based data management for blood banks and diagnostic labs is also gaining prominence, ensuring real-time access and improved workflow.
Emerging Developments in the Immunohematology Market
The Immunohematology market is changing as next-generation sequencing (NGS) is incorporated into the complicate antibody screening. To develop smaller and automated analyzers, manufacturers are keen on producing models that diagnose faster and have minimal human error. Mobile blood testing units are being invested on as start-ups and international companies seek to make blood testing more accessible in rural locations. Strategic alliances between blood banks and diagnostic labs are on the rise so as to make operations more efficient and data more accurate. Transfusion medicine is also becoming personalized as HLA and RBC genotyping fortifies.
Major Companies in the Immunohematology Market
- Bio-Rad Laboratories, Inc.
- Grifols, S.A.
- Immucor, Inc.
- Ortho Clinical Diagnostics
- Becton, Dickinson and Company
- Siemens Healthineers
- Beckman Coulter, Inc.
- Thermo Fisher Scientific
- Fresenius Kabi AG
- Quotient Limited
How big is the Immunohematology Market : FAQ's
It was valued at USD 2.4 Billion in 2024 and is projected to reach USD 3.5 Billion by 2031.
The immunohematology market is expected to grow at a CAGR of 5.5% from 2025 to 2031.
Increased transfusion needs, better diagnostic tools, and government safety initiatives.
Used in blood typing, antibody screening, transfusion services, and prenatal testing.
North America leads, while Asia-Pacific shows rapid growth due to expanding healthcare access.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com